Because this action is directly related to blood glucose levels, it can reduce the risk of hypoglycemia
However, with proper management, most individuals can mitigate these effects and enjoy the significant benefits Zepbound offers
Jiang explained that SUSTAIN-China showed average blood sugar was reduced by 1.4 percent to 1.7 percent with semaglutide after 30 weeks, whereas with ecnoglutide it dropped by 1.89 percent to 1.91 percent after 32 weeks (shown in the separate study)
Tirzepatide is the active ingredient in Mounjaro and Zepbound, FDA-approved for type 2 diabetes and chronic weight management
This is a benign accumulation of fatty tissue beneath the skin that can appear as firm, sometimes painless swellings
Link to Study Resources: Lojo, N., Medvidovic-Grubisic, M., & Drmic, D